Skip to content

Precigen PGEN Accrued Expenses

Accrued Expenses at other companies

Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$8.36M+64.1%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$11.69M+49.8%
Arrowhead Research logo
Arrowhead ResearchARWR
$20.37M+22.6%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$17M+408%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$13.11M
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$39.34M+17.6%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's accrued expenses?
Precigen (PGEN) reported accrued expenses of $4.56M in Q1 2026.
How has Precigen's accrued expenses changed year-over-year?
Precigen's accrued expenses decreased by 52.6% year-over-year, from $9.62M to $4.56M.
What is the long-term trend for Precigen's accrued expenses?
Over 5 years (2020 to 2025), Precigen's accrued expenses has grown at a 4.7% compound annual growth rate (CAGR), from $8.1M to $10.2M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.